Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT) [clinicaltrials:NCT00868465]

Bio2RDF identifier

NCT00868465

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00868465

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00868465

acronym [clinicaltrials_vocabulary:acronym]

TRANSACT

http://www.w3.org/2001/XMLSchema#string

anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]

600

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT00868465 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00868465/arm-group/c4ca4238a0b923820dcc509a6f75849b]

NCT00868465 arm group c81e728d9d4c2f636f067f89cc14862c [clinicaltrials_resource:NCT00868465/arm-group/c81e728d9d4c2f636f067f89cc14862c]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:35201a83c4b1cbf7b61aa5ecd1c82a7e

brief summary [clinicaltrials_vocabulary:brief-summary]

Artemisinin combination ...... eatment malaria transmission.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Treatment Efficacy and Malaria ...... Combination Therapy (TRANSACT)

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

To determine the clinical efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated falciparum malaria in children living in north-western Tanzania and in western Kenya. during 42 day follow-up [clinicaltrials_resource:aa1071942c36a812a4c8098e81f25e79]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

To determine the clinical efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated falciparum malaria in children living in north-western Tanzania and in western Kenya. during 42 day follow-up [clinicaltrials_resource:626da8830159a380ea669d09a4a45dd5]

To determine the clinical efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated falciparum malaria in children living in north-western Tanzania and in western Kenya. during 42 day follow-up [clinicaltrials_resource:70879f30615f3addee431a2f92da11a9]

To determine the clinical efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated falciparum malaria in children living in north-western Tanzania and in western Kenya. during 42 day follow-up [clinicaltrials_resource:89df0efad824203c6f580837dda07c33]

To determine the clinical efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated falciparum malaria in children living in north-western Tanzania and in western Kenya. during 42 day follow-up [clinicaltrials_resource:b65ddf838cc553be0770354fdf87277d]

To determine the clinical efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated falciparum malaria in children living in north-western Tanzania and in western Kenya. during 42 day follow-up [clinicaltrials_resource:c52ae624e1628dc5d63bb25d66785e11]

To determine the clinical efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated falciparum malaria in children living in north-western Tanzania and in western Kenya. during 42 day follow-up [clinicaltrials_resource:d63d0cc507440c59c222ee52b33593ce]

To determine the clinical efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated falciparum malaria in children living in north-western Tanzania and in western Kenya. during 42 day follow-up [clinicaltrials_resource:eb79adfc745fe27e213a87df9ff32125]

collaborator [clinicaltrials_vocabulary:collaborator]

Radboud University [clinicaltrials_resource:9d054a5e769edc50ebccbe7e6e89d041]

completion date [clinicaltrials_vocabulary:completion-date]

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

2.1 MALARIA AND ITS TRA ...... otential of mutant parasites.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00868465 [clinicaltrials_resource:b0936cae6df3597971ff28e6e0bd63e0]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2009-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

No

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Artemether-Lumefantrine [clinicaltrials_resource:108cc1f87f604baeaefb9e2a06517e8b]

Dihydroartemisinin-piperaquine [clinicaltrials_resource:d9e5427e15228bc38946940acdf95d5b]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Dihydroartemisinin [clinicaltrials_resource:01ff81f4a1524adfdcd1f907fa736613]

Piperaquine [clinicaltrials_resource:30d83e2d2833a19bebbd226dec9b9eeb]

Lumefantrine [clinicaltrials_resource:4cbe3db9e7c9f38f1e48f8e29bda968d]

Artemisinins [clinicaltrials_resource:96b0aebdf7b41a44a461b1bcb603a0d2]

Artemether-lumefantrine combination [clinicaltrials_resource:c36b1588e6a76b1d1ecc7ef43a4fc051]

Artemether [clinicaltrials_resource:e1f33059c767af2ef5759bf7b3f7832e]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

No

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2010-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Radboud University [clinicaltrials_resource:9d054a5e769edc50ebccbe7e6e89d041]

location [clinicaltrials_vocabulary:location]

International Centre for Insect Physiology and Ecology - St. Judes Clinic [clinicaltrials_resource:a993c27d8184b1bb35fb6cca320d7511]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00868465

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

2

http://www.w3.org/2001/XMLSchema#integer

org study id [clinicaltrials_vocabulary:org-study-id]

TRANSACT09

http://www.w3.org/2001/XMLSchema#string

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Tanzania: National Institute for Medical Research [clinicaltrials_resource:4cbe399fd703101ee3c46fad2e50be53]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reference [clinicaltrials_vocabulary:reference]

15388456 [pubmed:15388456]

16544256 [pubmed:16544256]

responsible party [clinicaltrials_vocabulary:responsible-party]

Teun Bousema, Kilimanjaro Christian Medical Centre [clinicaltrials_resource:d1b9862b2ec50757c6a4e27c97e95c64]

source [clinicaltrials_vocabulary:source]

Radboud University [clinicaltrials_resource:9d054a5e769edc50ebccbe7e6e89d041]

start date [clinicaltrials_vocabulary:start-date]

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00868465 study design [clinicaltrials_resource:07aaac41805b4ab4e86371ef203f8717]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00868465

verification date [clinicaltrials_vocabulary:verification-date]

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00868465

http://www.w3.org/2001/XMLSchema#string

title

Treatment Efficacy and Malaria ...... Combination Therapy (TRANSACT)

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Treatment Efficacy and Malaria ...... ) [clinicaltrials:NCT00868465]

@en